Novo Nordisk wins EU approval for Wegovy weight-loss pill
The oral semaglutide formulation clears European regulators, extending the franchise beyond injectables.
MH
By Maren Holt · Senior Reporter, GLP-1
Jul 15 03:00 ETSource: Reuters
The wire
- 01Reuters reports Novo Nordisk received European Union approval for its oral Wegovy weight-loss tablet.
- 02An approved oral semaglutide option changes prescribing and supply logistics for clinicians and pharmacies handling injectable pens.
- 03Launch timing, pricing and reimbursement across EU member states were not detailed in the report.
From the source
Read at reuters.comNovo Nordisk wins EU approval for Wegovy weight-loss pill